CGN Nuclear Technology Development Co Ltd (000881) fair value: what the stock is really worth
As of Sep 22, 2026: fair value of CGN Nuclear Technology Development Co Ltd ¥1.64, price ¥6.67, upside -75.4%, quality 46 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CGN Nuclear Technology Development Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range ¥5.00 – ¥13.87 · fair‑value band ¥0.9700 – ¥2.30 · the ¥6.67 price screens above the ¥1.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow CGN Nuclear Technology Development Co in your weekly email
Every Wednesday you see whether CGN Nuclear Technology Development Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators.
Show more
CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services. In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products. Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.
Stock analysis
CGN Nuclear Technology Development Co Ltd (000881) currently trades at ¥6.67, while our model-based Fair Value estimate is ¥1.64, implying the stock looks roughly 306.7% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 85/100, which puts the evidence level at low.
Scenario range: ¥0.9700 (bear) to ¥2.30 (bull), the price of ¥6.67 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Industrials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
CGN Nuclear Technology Development Co Ltd reported revenue of 5.6B CNY in FY2025 versus 8.0B CNY in FY2021, a compound −8.7%/yr. Reported net income was −287M CNY in FY2025.
Key figures
Market cap 6.3B CNY (≈ $941M) · P/S ratio 1.20 · EPS (TTM) ¥−0.3000 · Dividend yield 1.1% · Net margin −5.2% · Return on equity −5.6% · Return on assets (EBIT) −0.7% · Operating margin −4.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).
What moves the price
The share trades about 30% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at 15% fair-value upside, at −75%, 000881 screens richer than that median.
Fair Value models
Bear ¥0.9700Fair Value ¥1.64Bull ¥2.30
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−10.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.5%
Start year 2020 (pandemic). Over 10 years: +10.0% a year
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
4.6% (2020) → −1.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare CGN Nuclear Technology Development Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 380 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score44 · Below median
Fair Value upside−75% · Bottom 25%
Profitability
Return on assets−1% · Bottom 25%
Net margin (TTM)−5% · Bottom 25%
Operating margin (TTM)−5% · Bottom 25%
Growth and dividend
Revenue growth2% · Below median
Dividend yield (TTM)1.1% · Below median
Balance sheet
Debt / equity0.11× · Below median
Valuation Multiplesvs Conglomerates median · lower = cheaper
P/B0.19× · Cheapest 25%
P/S (TTM)0.17× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)9· sector 16
PAST (return on equity)0· sector 19
HEALTH (low debt)95· sector 89
DIVIDEND (yield)21· sector 40
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CGN Nuclear Technology Development Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/000881
Frequently asked questions
Is CGN Nuclear Technology Development Co Ltd (000881) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of ¥1.64 versus a price of ¥6.67, about −75% upside (overvalued).
What is the fair value of 000881?
Our model-based fair value for CGN Nuclear Technology Development Co Ltd is ¥1.64 (as of Sep 23, 2026), built from audited fundamentals. The current price: ¥6.67.
What is the quality score of 000881?
CGN Nuclear Technology Development Co Ltd has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CGN Nuclear Technology Development Co Ltd (000881)?
Our model-based price target is the fair value of ¥1.64 (as of Sep 23, 2026) from 2 valuation models. Cautious scenario ¥0.9700, optimistic scenario ¥2.30. It is a calculation from audited fundamentals, not an analyst target.
What is the CGN Nuclear Technology Development Co Ltd stock forecast for 2026?
Our models put fair value at ¥1.64, about −75% upside versus a price of ¥6.67 (overvalued). Cautious scenario ¥0.9700, optimistic scenario ¥2.30. The calculation is refreshed regularly with new filings.
What is the revenue of CGN Nuclear Technology Development Co Ltd (000881)?
CGN Nuclear Technology Development Co Ltd reported trailing-twelve-month revenue of about 5.6B CNY (latest available figure, as of Sep 23, 2026).
Does CGN Nuclear Technology Development Co Ltd pay a dividend?
CGN Nuclear Technology Development Co Ltd currently shows a dividend yield of about 1.05% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of CGN Nuclear Technology Development Co Ltd (000881)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CGN Nuclear Technology Development Co Ltd it is ¥1.64 per share (as of Sep 23, 2026), against a price of ¥6.67. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is CGN Nuclear Technology Development Co Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 000881 trades above its calculated fair value: price ¥6.67, fair value ¥1.64, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 000881?
No. The price is what the market pays today (¥6.67); the fair value is what the company's own numbers justify (¥1.64). For CGN Nuclear Technology Development Co Ltd the two are ¥5.03 per share apart. That gap is exactly why we show both numbers side by side.
How much is CGN Nuclear Technology Development Co Ltd worth?
The market values CGN Nuclear Technology Development Co Ltd at about 6.3B CNY (market capitalisation, as of Sep 23, 2026). Per share that is ¥6.67; our models calculate a fair value of ¥1.64 per share.
What do the bullish and bearish scenarios say about 000881?
Our models span a range for CGN Nuclear Technology Development Co Ltd: cautious scenario ¥0.9700, base ¥1.64, optimistic ¥2.30 per share (as of Sep 23, 2026, price ¥6.67). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of CGN Nuclear Technology Development Co Ltd (000881)?
Balance-sheet figures for CGN Nuclear Technology Development Co Ltd (as of Sep 23, 2026): return on equity −5.6%, debt of 0.11 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is 000881 from its 52-week high?
CGN Nuclear Technology Development Co Ltd trades at ¥6.67, about 30% below its 52-week high of ¥9.59 and 9% above the low of ¥6.12 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥1.64 is for.
Which stocks are comparable to CGN Nuclear Technology Development Co Ltd?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, CITIC Limited, Poste Italiane S.p.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CGN Nuclear Technology Development Co Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price ¥6.67, calculated fair value ¥1.64 (−75%), Quality Score 46/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 000881 calculated?
We run CGN Nuclear Technology Development Co Ltd through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥1.64, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. CGN Nuclear Technology Development Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CGN Nuclear Technology Development Co Ltd (000881)?
The closing price on Sep 22, 2026 was ¥6.67. Our model-based fair value is ¥1.64, about −75% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CGN Nuclear Technology Development Co Ltd right now?
The price sits above even our optimistic bull case (¥2.30). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (¥0.9700 to ¥2.30) leaves room in how you read the outcome.
Key figures of CGN Nuclear Technology Development Co Ltd
How large is the market capitalisation of CGN Nuclear Technology Development Co Ltd (000881)?
The market capitalisation of CGN Nuclear Technology Development Co Ltd is 6.3B CNY (≈ $941M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CGN Nuclear Technology Development Co Ltd (000881)?
The price-to-sales ratio of CGN Nuclear Technology Development Co Ltd is 1.20 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CGN Nuclear Technology Development Co Ltd (000881)?
Earnings per share at CGN Nuclear Technology Development Co Ltd are ¥−0.3000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of CGN Nuclear Technology Development Co Ltd (000881)?
The dividend yield of CGN Nuclear Technology Development Co Ltd is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CGN Nuclear Technology Development Co Ltd (000881)?
The net margin of CGN Nuclear Technology Development Co Ltd is −5.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CGN Nuclear Technology Development Co Ltd (000881)?
The return on equity (ROE) of CGN Nuclear Technology Development Co Ltd is −5.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CGN Nuclear Technology Development Co Ltd (000881)?
On an EBIT basis the return on assets of CGN Nuclear Technology Development Co Ltd is −0.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CGN Nuclear Technology Development Co Ltd (000881)?
The operating margin of CGN Nuclear Technology Development Co Ltd is −4.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CGN Nuclear Technology Development Co Ltd (000881)?
Revenue at CGN Nuclear Technology Development Co Ltd is growing +1.8% versus a year earlier (3y avg −7.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CGN Nuclear Technology Development Co Ltd (000881)?
Earnings per share at CGN Nuclear Technology Development Co Ltd are growing −98.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does CGN Nuclear Technology Development Co Ltd (000881) generate?
The free cash flow of CGN Nuclear Technology Development Co Ltd is −211M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does CGN Nuclear Technology Development Co Ltd (000881) carry?
The net debt of CGN Nuclear Technology Development Co Ltd is 980M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch CGN Nuclear Technology Development Co Ltd in the live analysis
One click puts CGN Nuclear Technology Development Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
